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Our understanding of the sources of Mycobacterium avium infection is partially based on genotypic matching of pathogen iso-
lates from cases and environmental sources. These approaches assume that genotypic identity is rare in isolates from unlinked
cases or sources. To test this assumption, a high-resolution PCR-based genotyping approach, large-sequence polymorphism
(LSP)-mycobacterial interspersed repetitive unit–variable-number tandem repeat (MIRU-VNTR), was selected and used to ana-
lyze clinical and environmental isolates of M. avium from geographically diverse sources. Among 127 clinical isolates from seven
locations in North America, South America, and Europe, 42 genotypes were observed. Among 12 of these genotypes, matches
were seen in isolates from apparently unlinked patients in two or more geographic locations. Six of the 12 were also observed in
environmental isolates. A subset of these isolates was further analyzed by alternative strain genotyping methods, pulsed-field gel
electrophoresis and MIRU-VNTR, which confirmed the existence of geographically dispersed strain genotypes. These results
suggest that caution should be exercised in interpreting high-resolution genotypic matches as evidence for an acquisition event.
Members of theMycobacterium avium complex (MAC) live innatural soils andwater sources, commercial soils and treated
water, and other human-made niches (1, 2). At least some strains
cause diseases in susceptible humans, including lymphadenitis in
children, disseminated disease in severely immunocompromised
individuals, and lung disease associated with several clinical pro-
files (3). MAC comprises two major species, M. avium and M.
intracellulare, as well as minor species and members that are not
classified into species (4–8).M. avium is further divided into sub-
species, M. avium subsp. avium, M. avium subsp. silvaticum, M.
avium subsp. paratuberculosis, and M. avium subsp. hominissuis
(9). Even within a single group, genomes can vary markedly
among strains (10).
High-resolution genotypic fingerprints are taken to be uniquely
associated with specific strains of the MAC. Several methods have
been used to generate high-resolution genetic fingerprints of the
MAC. These include pulsed-field gel electrophoresis (PFGE) (11),
restriction-fragment-length polymorphism (RFLP) analysis using
insertion sequences (12, 13), repetitive-sequence-basedPCR (rep-
PCR) analysis (14, 15), randomly amplified polymorphic DNA
(RAPD) analysis (6), mycobacterial interspersed repetitive unit–
variable-number tandem repeat (MIRU-VNTR) analysis (16),
amplified fragment length polymorphism (ALFP) (17), (CCG)4-
based PCR analysis (18), and multispacer sequence typing (MST)
(19). These methods vary in the quantity and purity of DNA re-
quired for analysis and their portability (the ease with which re-
sults can be compared across analyses and exchanged among
laboratories). The hypothetical gold standard for validating geno-
typic fingerprinting methods is complete genome sequencing. In
practice, however, methods are compared on the basis of their
discriminatory index (DI), a quantity that reflects a method’s
probability of placing any two isolates into separate genotypic
groups (20). Some validation is provided by the fact that multiple
isolates from the same patient, either from separate anatomic sites
or taken over time, often have the same fingerprint (11, 12, 17, 21,
22). When matching or highly similar fingerprints are found be-
tweenpatients (17, 21–23), in the same environmental source over
time (22, 24), or between a patient and his environment (22, 23,
25–28), this is often interpreted as support for a link of some sort.
These kinds of matches are interpreted to indicate a shared source
of acquisition, continuous colonization, or probable source of ac-
quisition, respectively.
Despite the utility of this approach (29), it is noteworthy that
several studies using high-resolution genotyping methods have
found matches or clusters between cases with no apparent shared
sources (12, 15, 21, 30). Previous work in our laboratory used
large-sequence polymorphism (LSP) analysis (also known as de-
ligotyping) and rep-PCR to show that the M. avium genome se-
quence strain 104 was found in clinical isolate collections from
southern California and northwestern Washington (15). An ear-
lier study used rep-PCR and IS1245 RFLP to identify a group of
clinical isolates from these same two locations that shared another
genotype (14). More recently, an MIRU-VNTR analysis of 47 hu-
man isolates ofM. avium found high phylogenetic proximity be-
tween isolates collected over the course of 2 decades froma clinical
site in Italy (31). These observations suggest that some M. avium
genotypes are stable or have wide geographic distributions.
In order to more rigorously assess the wide geographical dis-
tribution of some MAC strains, this study used high-throughput
genotyping methods to characterize (179) geographically diverse
clinical and environmental isolates of M. avium. Many widely
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used M. avium genotyping methods, including IS1245 RFLP and
PFGE, have limited portability and require large quantities of
DNA. Thus, we chose to evaluate PCR-based typingmethods with
greater portability and smaller DNA requirements, i.e., 3= hsp65
sequencing, rep-PCR, MIRU-VNTR, and deligotyping, to find
one with sufficient reproducibility and discriminatory power for
use in the larger analysis. Twomethodswere then applied to larger
sets of isolates for our geographic analysis. Subsets were further
analyzed by PFGE and MIRU-VNTR.
MATERIALS AND METHODS
M. avium isolates. Genotypic analyses were carried out using subsets of a
largeM. avium isolate and DNA collection assembled at Seattle Biomed-
ical Research Institute (Seattle BioMed) and currently housed at the Uni-
versity of Washington (UW). Permanent cultures or genomic DNA of
archivedM.avium isolateswere received frommultiple collaborators. The
isolates and DNA samples used in this study were all previously described
(14, 15, 22–26, 28, 32–39) and are listed in Tables S1 to S3 in the supple-
mental material. Most isolates were identified to the species level. In total,
127 clinical M. avium isolates (each from a separate individual case) and
52 environmentalM. avium isolates were examined.
Bacterial culture and preparation of genomic DNA. For some iso-
lates, genomic DNA was received from collaborators. Isolates for which
permanent cultures were archived at Seattle BioMed were grown on
Middlebrook 7H10 containing 10% oleic acid-albumin-dextrose-catalase
(OADC; Fisher Scientific International, Hampton, NJ) at 37°C, and then
DNA was extracted by one of three methods: by boiling, using the
ArchivePure DNA cell/tissue kit (5 Prime, Gaithersburg, MD), or using
the UltraClean microbial DNA isolation kit (MoBio Laboratories, Carls-
bad, CA). The ArchivePure protocol was modified for mycobacteria as
shown in File S4 in the supplemental material. The MoBio kit was em-
ployed using the recommendations for mycobacterial species from Bac-
terial Barcodes, and for some isolates theMoBiomethod was modified by
adding a freeze-thaw step after suspending cells in bead solution but be-
fore vortexing, or as described previously (40). Extracted DNA ranged in
concentration from 10 to 250 ng/l and was not adjusted in the following
analyses unless otherwise noted.
PCR and sequencing of hsp65. A 1,059-bp portion of the variable 3=
end of the hsp65 gene was PCR amplified and sequenced. Amplification
primers were MAChsp65F_574 (5=-CGGTTCGACAAGGGTTACAT-3=)
and MAChsp65R (5=-ACTGACTCAGAAGTCCATG-3=), as reported in
Turenne et al. (41). PCRmixtures consisted of 5g of genomic DNA, 1
PCRbufferwithMgCl2, 0.2mMdeoxynucleoside triphosphates (dNTPs),
1 U of EconoTaq, (Lucigen, Middleton, WI), 1 M betaine, (Sigma, St.
Louis, MO), 5 M forward and reverse primer, and type 1 purified water
(Barnstead Nanopure) to adjust the final volume to 25l. Cycling condi-
tions were 95°C for 10 min, followed by 35 cycles of 95°C for 1 min, 55°C
for 1 min, and 72°C for 90 s, and then a final 10-min extension at 72°C.
Products were visualized by electrophoresis, purified with a QIAquick
spin PCR purification kit (Qiagen, Valencia, CA), and submitted for se-
quencing using an Applied Biosystems 3730XL genetic analyzer. PCR
primers and an additional primer (hsp65-1047R, 5=-GTAGTCGGAGTC
GGTGTTCT-3=) were used for sequencing. hsp65 codes were assigned
according to the nomenclature of Turenne et al. (41), and novel sequences
were reported to GenBank.
MIRU-VNTR analysis. MIRU-VNTR analysis was carried out using
primer sequences fromThibault et al. (16). For loci 3, 7, 10, 25, 32, 47, and
292, PCR mixtures consisted of 2.5 l genomic DNA extraction mix, 1
PCR buffer with MgCl2, 0.2 mM dNTPs, 1 U EconoTaq, 1 M betaine, 2.0
M each primer, and nanopure water to adjust the final volume to 25 l.
Reaction mixtures for loci 3 and 32 also contained 1.0 l of dimethyl
sulfoxide. For locus X3, the volume of genomic DNA extractionmix used
was reduced to 1l. Cycling conditions for loci 3, 7, 10, 25, 32, 47, and 292
were 10 min at 95°C, followed by 40 cycles of 95°C for 1 min, 58°C for 1
min, and 72°C for 30 s, and then a final 10min at 72°C. Cycling conditions
for reactions at locus X3 consisted of 5 min at 94°C, followed by 40 cycles
of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s, and then a final 10min at
72°C. Products were analyzed on 1.0 to 2.0% agarose gels stained with
ethidium bromide.
Because four of the eight MIRU loci described by Thibault et al. (16)
showed notably greater allelic diversity than the other four, we considered
both eight-locus and four-locus MIRU (alone or in combination with
other methods) as possible fingerprinting methods for this study. In par-
ticular, we evaluated the replacement of the four least-variableMIRU loci
with four LSP loci that appeared to be more variable, thereby achieving
greater resolution in a total of 8 PCRs. MIRU types were assigned to
represent the number of repeats inferred to be present from the product
length at that locus based on product sizes and repeat numbers from
Thibault et al. (16) and personal correspondence with V. Thibault and F.
Biet.
LSP analysis. LSP analysis was carried out at four genomic loci,
HSDR, LSP2 (also known asDA2), LSP7 (also known asDA7), and LSPP5
(also known as DEL11), using published primer sequences (15). For most
isolates, LSP analysis was carried out on 1 l of genomic DNA using the
GC-rich PCR system (RocheDiagnostics, Basel, Switzerland) as described
previously (15). For a small number of isolates, EconoTaq was used with
the following reaction mixture: 1 l genomic DNA, 1 PCR buffer with
MgCl2, 0.2 mMdNTPs, 1 U EconoTaq, 1M betaine, 0.6Meach primer,
and nanopure water to adjust the final volume to 25l. Visualization and
nomenclature techniques employed have been previously described (15).
LSP-MVR analysis. An eight-digit genotype combining information
from LSP and MIRU-VNTR analyses was assigned. The first four digits
represent results for the four LSP loci, and the last four digits represent
results for the MIRU-VNTR loci that showed the highest allelic diversity
in Thibault et al.: X3, 25, 32, and 47. We refer to this combined approach
as LSP-MVR analysis.
Rep-PCR. Rep-PCR was carried out using the Bacterial Barcodes my-
cobacterial kit (Athens, GA) as described previously (14, 15). Results for
isolates analyzed in separate PCRs and on separate chips were combined
into a single report using the Diversilab software, and letter type designa-
tions were assigned to branches of the dendrogram with at least 92%
average similarity.
PFGE. PFGE of M. avium isolates was carried out using previously
described methods (11). Patterns considered indistinguishable by the
Tenover criteria (29) were assigned numeric type designations.
Calculation of DI. Assessment of DIwas conducted on a 20% random
sample of all clinical M. avium isolates for which DNA was stored at
Seattle BioMed at the outset of the study. A uniform distribution in Mi-
crosoft Excel was used to assign a randomnumber between 0 and 1 to each
sample. Samples with random numbers of 0.20 or less (n  29) were
subjected to multiple genotyping methods. One of the selected genomic
DNA samples was exhausted before all methods could be applied, so 28
samples were used to evaluate discrimination. TheDI of eachmethodwas
calculated using the approach of Hunter (20) as implemented by BioPHP
at http://biophp.org/stats/discriminatory_power/demo.php.
Identification of GDCs.GenomicDNA froma convenience sample of
127 clinical M. avium isolates was subjected to LSP-MVR analysis. Each
clinical isolate was classified as having a unique genotype, sharing its ge-
notype only with other clinical isolates from the same location, or sharing
its genotype with at least one clinical isolate from another location. These
latter genotypes were termed “geographically dispersed clinical types,” or
GDC types.
Environmental comparison. Genomic DNA from a convenience
sample of 52 environmentalM. avium isolates was subjected to LSP-MVR
analysis.
Ethical review. This study was determined by the investigators to be
exempt from ethical review under 45 CFR 46.101.b.4.
Nucleotide sequence accession numbers. Novel hsp65 sequences
have been deposited in the GenBank database under accession numbers
FJ839884.1 and FJ839885.1.
Dirac et al.
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RESULTS
Selection of PCR-based genotyping methods. In order to assess
reproducibility within each method, DNA extracted from isolates
HMC02 and 104 was subjected to hsp65 sequencing 5 times, rep-
PCR 11 and 8 times, and LSP-MVR more than 7 times. Identical
hsp65 sequencing results were seen all five times. Eighty-five per-
cent of all possible pairwise comparisons between rep-PCR runs
of HMC02 (47 of 55) were 92% similar, and 88% (7 of 8) of
replicate rep-PCR runs of 104 were92% similar. LSP-MVR re-
sultswere identical forHMC02on every occasion and identical for
104 all but one time.
To compare DIs, all PCR-based methods were applied to the
panel of 28 randomly selected clinical isolates (see Table S1 in the
supplemental material). hsp65 sequencing alone had a DI of 0.58,
LSP of 0.87, four-locus MIRU of 0.84, eight-locus MIRU of 0.87,
and rep-PCR of 0.97 (Table 1). The combination of four LSP and
four MIRU-VNTR (LSP-MVR) loci improved the DI to 0.95.
When combined with LSP, the use of eight MIRU-VNTR loci did
not improve resolving power over the use of four MIRU-VNTR
loci (Table 1). Thus, LSP-MVR, with four LSP and four MIRU-
VNTR loci, exhibited high resolving power in a high-throughput,
portable, PCR-based method and was chosen as the first-line ap-
proach for further analysis.
Identification of geographically dispersed clinical strains.
Clinical M. avium isolates from 127 individuals were typed by
LSP-MVR. Of these, 24/127 (19%) had genotypes unique among
clinical isolates. The remaining 103 isolates had 1 of 18 nonunique
genotypes. Of these 18 nonunique genotypes, 6 genotypes were
found only in one geographic collection. Twelve genotypes were
found at more than one geographic location. Isolates exhibiting
these geographically dispersed clinical (GDC) genotypes ac-
counted for 50% (63/127) of all typed clinical isolates.
GDCs by location are shown in Fig. 1; other LSP-MVR geno-
types observed among clinical isolates are shown in Table S5 in the
supplemental material. GDC1 includes isolate HMC02 and some
genotypically similar isolates previously identified by rep-PCR
and IS1245 RFLP (14, 15). GDC6 and GDC7 both contain some
isolates previously characterized by rep-PCR as 104-like (14, 15).
Strain 104 itself shared its LSP-MVR type only with other clinical
isolates from its region of isolation, southernCalifornia. The other
GDCs have not previously been described.
Although 8-locus MIRU-VNTR had a lower DI than LSP-
MVR (Table 1), it is a widely used method that increased in pop-
ularity over the course of this study. Therefore, a post hoc analysis
was conducted to determine if GDCs identified by LSP-MVR
would have been identified if the main analysis had been carried
out by using 8-locus MIRU-VNTR instead. Complete 8-locus
MIRU-VNTR types were determined for the isolates randomly
selected to evaluate the DIs of genotyping methods (see Table S1
in the supplemental material) and for the isolates selected for
PFGE analysis (Table 2). Thus, 8-locusMIRU-VNTR results were
available for at least two isolates from different geographical loca-
tions within 4GDCs defined by LSP-MVR (GDC1, GDC2, GDC3,
andGDC7). Three of the 4GDCs containedmultiple isolates from
different locations with the same 8-locus MIRU-VNTR genotype
(see Table S6 in the supplemental material). Therefore, these
GDCswould have been identified if this widely used approach had
been employed in the main analysis.
A subset of clinical isolates was further analyzed by PFGE (Fig.
2). These isolates were chosen for their membership in GDCs
defined by LSP-MVR and the availability of permanent cultures
(required for PFGE). For two GDCs (GDC1 and GDC7), at least
one isolate frommore than one geographic location was available
for PFGE analysis (Table 2). In both of these GDCs, two isolates
from distant sites exhibited indistinguishable PFGE patterns.
GDC genotypes among environmental isolates. The occur-
rence of GDC genotypes in the environment was investigated.M.
avium isolates from 52water, food, and soil samples were typed by
LSP-MVR. Thirty-three isolates (out of 52; 63%) from two dis-
tinct western U.S. geographic locations shared a single genotype,
GDC1. Five additional GDCs were observed (GDC5, GDC9,
GDC10, GDC11, and GDC12) in environmental collections, ac-
counting for 13 additional isolates (out of 52; 25%). Only six en-
vironmental isolates (out of 52; 12%) had genotypes not observed
in the clinical collections. Genotypes observed among environ-
mental isolates by location are shown in Table S7 in the supple-
mental material.
DISCUSSION
Studies on the epidemiology and etiology of MAC diseases have
often compared the genetic fingerprints of MAC isolated from
patients’ clinical specimens and the environments to which those
patients have been exposed (22, 23, 25–28). Few of these studies
were conducted in a comparative fashion, and the underlying dis-
tribution ofMAC in the environment is only partially understood.
To date, we know of only one comparative study, that of Fujita et
al. (42), that included MAC isolated from the environments of
nondiseased individuals.
Studies of the epidemiology ofM. tuberculosis have been aided
by the use of PCR-based strain typing methods, namely, MIRU-
VNTR and spoligotyping. The portability of thesemethods is such
that results generated by independent investigators around the
world can be fed into unified numerical databases (43, 44). At the
outset of the present study, no such portable methods had
emerged for MAC. Therefore, we combined two previously re-
ported, moderate-resolution methods, LSP analysis and MIRU-
VNTR (15, 16), to yield a simple, highly reproducible approach
with resolving power that approaches those of well-characterized
methods such as PFGE and IS1245-RFLP. LSP-MVR is inexpen-
sive to perform, requires only small amounts of DNA, and yields
portable results.
LSP-MVR analysis identified distinct genotypic groups among
M. avium isolates from clinical cases separated by distance and
without identified epidemiologic links. Forty-two genotypes were
TABLE 1 Discriminatory indices of genotyping methods for
Mycobacterium avium
Methoda
Discriminatory index of method plus:
Alone hsp65 LSP
4-Locus
MIRU
8-Locus
MIRU Rep-PCR
hsp65 0.58 0.91 0.89 0.91 0.98
LSP 0.87 0.95 0.95 0.97
4-Locus MIRU 0.84 0.98
8-Locus MIRU 0.87 0.98
Rep-PCR 0.97
a hsp65, sequencing of a 1,059-bp portion of the 3= end of the gene for heat shock
protein 65; LSP, large-sequence polymorphism analysis; 4-locus MIRU, MIRU-VNTR
analysis using loci X3, 25, 32 and 47; 8-locus MIRU, MIRU-VNTR analysis using loci
292, X3, 25, 47, 3, 7, 10, and 32; rep-PCR, repetitive-sequence-based PCR.
Geographically Dispersed Genotypes of M. avium
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observed among 127 clinical isolates. Twelve genotypes (GDC1 to
GDC12) were observed at multiple geographic locations, isolated
from patients with no apparent connection to each other. This
may reflect common exposure to commercial products, such as
food or potting soil, which are shipped across long distances and
are known to be colonized by MAC (1, 26). It may also reflect the
presence of these genotypes in environmental sources at multiple,
distant locations. These genotypes may have traits that favor ex-
posure to humans, such as survival in shipped products, built
environments, domestic water supplies, or domesticated animals.
Theymay have characteristics that favor colonization, invasion, or
pathogenicity in human hosts.
Alternatively, these results could be an artifact of the genotyp-
ing approach. These results were obtained using a novel method,
but it is likely that other established genotyping methods would
yield similar results for several reasons. First, LSP-MVR showed
good resolving power. It displayed a DI of 0.95 in a random set of
clinical M. avium isolates. This value approached a DI of 0.97,
which was observed for rep-PCR using the same isolates, and ex-
ceeded that of the widely used 8-locus MIRU-VNTR (0.87).
Second, the existence of GDCs has been partially corroborated
by use of other methods: IS1245-RFLP, PFGE, rep-PCR, and
MIRU-VNTR. Three GDCs identified in the present study,
GDC1, GDC6, and GDC7, include isolates previously reported to
share IS1245-RFLP patterns (14, 15). In the present study, GDC1
and GDC7 contained geographically distant members that shared
PFGE patterns. Likewise, for the four GDCs identified by LSP-
MVR in this study that had sufficient 8-locus MIRU-VNTR data
to evaluate (GDC1 to GDC3 and GDC7), 3 of 4 GDCs were con-
firmed. Thus, the combined high-resolution genotypic data sup-
port the conclusion that some genotypes are geographically wide-
spread.
Our observations are consistent with a recent MIRU-VNTR
study of 47 clinical isolates collected over 2 decades from a single
clinical site in Italy (31). Although the Italian isolates were not
separated geographically, the authors concluded that some M.
FIG 1 Geographic distribution of LSP-MVR genotypes of clinicalMycobacterium avium. The size of a pie chart is proportional to the number of cases from each
location included in the analysis. Yellow circles on the map correspond to catchment areas of the clinical laboratory(ies) providing isolates or DNA for analysis.
GDCs were defined by the same LSP-MVR type being found for at least one clinical isolate at each of two ormore geographical locations. LSP-MVR digits of type
represent loci HSDR, DA2/LSP2, DA7/LSP7, DEL11/LSPP5, X3, 25, 32, and 47 (21, 39). “1” is used to indicate the absence of the large-sequence polymorphism,
which corresponds to product lengths of 343 bp (for HSDR), 834 bp (for DA2/LSP2), 329 bp (for DA7/LSP7), and 728 bp (for DEL11/LSPP5). “2” is used to
indicate the presence of the large-sequence polymorphism, which corresponds to product lengths of 480 bp (for HSDR), 954 bp (for DA2/LSP2), 181 bp (for
DA7/LSP7), and 794 bp (for DEL11/LSPP5) (21); digits for MIRU-VNTR type represent the number of repeats inferred from the product length at that locus
based on product sizes and repeat numbers from Thibault et al. (16) and personal correspondence with V. Thibault: 196 bp when 2 repeats of 53 bp are present
(locus X3), 350 bp when 3 repeats of 58 bp are present (25), 298 bp when 8 repeats of 18 bp are present (32), and 217 bp when 3 repeats of 35 bp are present (47).
LSP-MVR types of GDCs are as follows: GDC1, 2112-3383; GDC2, 1111-5282; GDC3, 1121-3282; GDC4, 1211-2483; GDC5, 1211-4282; GDC6, 1221-3282;
GDC7, 1221-4282; GDC8, 2211-2283; GDC9, 2212-3383; GDC10, 1121-2282; GDC11, 1121-4282; andGDC12, 2112-5383. Local strains were defined by finding
the same LSP-MVR type for two or more clinical isolates at a single geographic location but not being found among clinical isolates from other geographic
locations; unique types were found for a single isolate in the entire set of clinical genotypes. Environmental isolates are not included in these numbers and were
not considered in GDCdesignations. Genotypes for local clusters and unique types are shown in Table S5 in the supplemental material. Themap is adapted from
aWikimedia Commons map (http://commons.wikimedia.org/wiki/File:A_large_blank_world_map_with_oceans_marked_in_blue-edited.png) published un-
der a Creative Commons agreement.
Dirac et al.
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avium genotypes are stable over time and can be associated with
epidemiologically unlinked cases. Our study, which applied a
higher-resolution method (LSP-MVR) to a larger and more di-
verse sample set (179 clinical and environmental isolates from
geographically distinct sources), confirms and extends these con-
clusions.
Six GDC genotypes (GDC1, GDC5, GDC9, GDC10, GDC11,
and GDC12) were observed in isolates from environmental sam-
ples. Therefore, GDC genotypes are not unique to clinical isolates.
Genotypic diversity appeared to be lower among the environmen-
tal isolates examined than among the clinical isolates examined.
Limited genotypic diversity among environmental isolates has
been reported elsewhere (23, 24) and must be interpreted with
caution. It may be due to selection by methods of sample collec-
tion, decontamination, and culture or peculiarities of the environ-
ments represented in the convenience sample typed. It also
implies that high-resolution genotypingmethods that were devel-
oped for use with clinical MAC isolates do not have the same
ability to distinguish environmental isolates. In other words, the
molecular markers that vary among clinical MAC strains may be
less variable among environmental strains despite a high level of
diversity at other loci. Alternatively, it may reflect truly low geno-
typic diversity amongM. avium strains in any given environment.
The greater diversity seen among clinical isolates may reflect the
fact that humans are exposed to many different environments;
thus, they are able to reflect the diversity across different environ-
ments more effectively than purposeful environmental sampling.
Our results suggest that caution should be employed in inter-
preting genotypic matches between clinical and environmental
isolates in studies of MAC lung disease that do not include appro-
priate control subjects. Matches between rarely observed geno-
types ofM. aviummay provide evidence for an acquisition event,
but the observation of common genotypes at distant sites shows
that some genotypicmatches can occur in the apparent absence of
an epidemiologic link.WhenTenover et al. presented their criteria
for interpreting PFGE data in epidemiologic investigations, they
emphasized that high-resolution genotypic data should be applied
in the context of an outbreak investigation with a defined time
frame, knowledge of the strains of a pathogen that are endemic to
the region, and other epidemiologic data (29). The importance of
this context was recently noted by investigators of a nationwide
Salmonella outbreak associated with fresh produce (45).
This context is infrequently present in studies of human dis-
ease caused by MAC. The timing of etiologically relevant expo-
sures is unknown, and the underlying distribution of strains in the
environment is poorly characterized. In genotypic studies to date,
other epidemiologic data are often limited and comparator
groups are rarely included. Comparison to representative control
subjects or development of an expanded worldwide genotypic da-
tabase will facilitate the interpretation of molecular epidemiolog-
ical data in studies of MAC disease. Use of PCR-based genotyping
technologies with portable, numerical results, such as LSP-MVR,
TABLE 2 PFGE results for some clinical isolates sharing GDCa
genotypes
Name and
LSP-MVR
typeb Isolate name Site PFGE pattern
GDC1
2112-3383 4904 Montreal, Canada 10
HMC02 Seattle Not interpretable
108 Southern California 11
W355 Southern California 10
03240 Montreal 13
GDC7
1221-4282 W214 Southern California 7
HMC08 Seattle 7
HMC24 Seattle 4
W216-8 Southern California 5
105 Southern California 8
a GDCs, geographically dispersed clinical strains. GDCs were defined by the same LSP-
MVR type being found for at least one clinical isolate at each of two or more
geographical locations.
b LSP-MVR and PFGE types are given for all members of LSP-MVR-defined GDCs for
which archived cultures from more than one location were available for PFGE analysis;
identity by PFGE of isolates from distant geographic locations could be tested only for
GDC1 and GDC7.
FIG 2 Pulse-field gel electrophoresis of M. avium clinical isolates. Isolates were selected for this analysis as described in the text. (A) Analysis of 11 isolates,
including four fromGDC1 and three fromGDC7. (B) Analysis of 14 isolates, including one fromGDC1 and two fromGDC7.Data at the top of each lane indicate
the isolate identity. Numbers at the bottom of each lane indicate different PFGE patterns (isolates with the same horizontal number have indistinguishable
patterns). DNA markers in the far right lane (from bottom to top) are 48.5, 97.0, 145.5, and 194.0 bp. NI, not interpretable.
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will further assist in large-scale,multisite studies and development
of shared databases.
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